House Appropriators Watch Clock On OTC Cough/Cold, Sunscreen Monographs
This article was originally published in The Tan Sheet
Executive Summary
House appropriators recommend FDA in June publish a proposed rule for safety and efficacy of cough/cold OTCs in pediatric populations They also direct FDA by December to complete its review of the remaining sunscreen ingredient safety and effectiveness TEA submissions.
You may also be interested in...
Ambitious Schedule For OTC Monograph Updates On FDA Unified Agenda
Nearly two-thirds of FDA’s planned regulatory actions for the consumer health segment would update the OTC drug monograph, including changes to pediatric cough/cold labeling, acetaminophen dosing, oral care products with benzocaine and labeling for some laxatives.
Ambitious Schedule For OTC Monograph Updates On FDA Unified Agenda
Nearly two-thirds of FDA’s planned regulatory actions for the consumer health segment would update the OTC drug monograph, including changes to pediatric cough/cold labeling, acetaminophen dosing, oral care products with benzocaine and labeling for some laxatives.
House Appropriators Push For Revised Pediatric Cough/Cold Labels
House appropriators want FDA to propose by Dec. 31 revised labeling for OTC pediatric cough and cold products that addresses safety and efficacy concerns.